Rare Disease Day: Why Clinical Trial Travel Support Matters for Patients

Rare Disease Day

Every February, Rare Disease Day shines a spotlight on the millions of individuals and families living with rare conditions. While a single rare disease may affect a small population, over 300 million people worldwide live with a rare disease. For many of these patients, clinical trials are not just an option, they are often the only path to treatment and hope.

Yet access to clinical trials comes with challenges that go beyond medical eligibility. Travel distance, out-of-pocket expenses, time away from work, and administrative complexity can all become barriers to participation. This is why clinical trial travel and expense support plays a critical role in rare disease research.

The Role of Clinical Trials in Rare Disease Research

Clinical trials are essential to advancing therapies for rare diseases. Because patient populations are small, studies are often limited to a handful of specialized research sites, requiring patients to travel long distances to participate.

Without structured travel and reimbursement support, many patients would be unable to enroll or remain in a study. Missed visits and patient withdrawals can delay research timelines and impact data integrity. Supporting patients logistically helps ensure trials stay on track while improving the overall patient experience.

Reducing Barriers Through Clinical Trial Travel and Expense Management

At Colpitts Clinical, we manage clinical trial travel and expense logistics so patients can focus on their health, not the financial or administrative burden of participation.

Our work supports patients across therapeutic areas, including rare and orphan diseases, by coordinating:

Airfare, lodging, and ground transportation
Reimbursement for trial-related expenses
Clear communication around travel and payments
Compliant, patient-friendly processes

This support is especially important for rare disease patients, who often face long-term care needs and ongoing financial strain.

Patient Stories: How Travel Support Enables Trial Participation

Supporting families in pediatric rare disease trials
We frequently work with families traveling for pediatric rare disease studies. In one case, a parent needed to fly several states away multiple times with their child to attend study visits. By managing travel arrangements and ensuring timely reimbursements, we helped remove financial stress, allowing the family to remain fully engaged in the trial.

Helping working adults stay enrolled in research
Some rare disease patients balance full-time work while participating in a clinical trial. When travel expenses and unpaid time off add pressure, patients may consider withdrawing. Providing reliable travel coordination and reimbursement helps reduce that burden and supports continued participation.

Enabling elderly patients to participate in rare disease research
Older patients with rare conditions may be hesitant to join trials due to mobility challenges or complex reimbursement requirements. Simplified travel planning and hands-on support make participation possible, ensuring broader and more representative trial enrollment.

Why Rare Disease Day Matters to Clinical Research

Rare Disease Day is more than awareness, it is a call to action. It highlights the importance of removing barriers so patients can access clinical trials safely, equitably, and with dignity.

When sponsors and research sites prioritize patient-centric clinical trial travel support, they improve recruitment, retention, and trust, all of which are essential for successful rare disease studies.

Our Commitment to Rare Disease Patients

At Colpitts Clinical, we specialize exclusively in clinical trial travel and expense management. We do not outsource this work. Our team understands the regulatory, financial, and emotional complexities involved in this research.

On Rare Disease Day, and every day, we are proud to support the patients who make clinical trials possible and the research teams working to bring new therapies to life. Advancing rare disease research means supporting the whole patient journey, not just the protocol.

How Clinical Trial Travel and Expense Management Drives Better Patient Retention

Equal Access to Clinical Trials Ensuring Successful Enrollment

Visit us on Facebook